Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription

Articles published in Neurosci Lett

Retrieve available abstracts of 151 articles:
HTML format

Single Articles

    September 2021
  1. GAO F, Liu T, Tuo M, Chi S, et al
    The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
    Neurosci Lett. 2021;765:136247.
    PubMed     Abstract available

  2. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    PubMed     Abstract available

  3. RADAGHDAM S, Karamad V, Nourazarian A, Shademan B, et al
    Molecular mechanisms of sex hormones in the development and progression of Alzheimer's disease.
    Neurosci Lett. 2021 Sep 6:136221. doi: 10.1016/j.neulet.2021.136221.
    PubMed     Abstract available

    August 2021
  4. RIZZI L, Balthazar MLF
    Mini-review: The suspected non-Alzheimer's disease pathophysiology.
    Neurosci Lett. 2021 Aug 31:136208. doi: 10.1016/j.neulet.2021.136208.
    PubMed     Abstract available

  5. WEI X, Xie L, Du P, Zhao Z, et al
    Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's Disease.
    Neurosci Lett. 2021 Aug 23:136196. doi: 10.1016/j.neulet.2021.136196.
    PubMed     Abstract available

  6. ZHAO N, Xu B
    The beneficial effect of exercise against Alzheimer's disease may result from improved brain glucose metabolism.
    Neurosci Lett. 2021 Aug 18:136182. doi: 10.1016/j.neulet.2021.136182.
    PubMed     Abstract available

    July 2021
  7. SHENG J, Wang L, Cheng H, Zhang Q, et al
    Strategies for multivariate analyses of imaging genetics study in Alzheimer's disease.
    Neurosci Lett. 2021;762:136147.
    PubMed     Abstract available

  8. WANDER CM, Song J
    The Neurogenic Niche in Alzheimer's disease.
    Neurosci Lett. 2021 Jul 13:136109. doi: 10.1016/j.neulet.2021.136109.
    PubMed     Abstract available

    June 2021
  9. SINGULANI MP, De Paula VJR, Forlenza OV
    Mitochondrial dysfunction in Alzheimer's disease: therapeutic implications of lithium.
    Neurosci Lett. 2021 Jun 20:136078. doi: 10.1016/j.neulet.2021.136078.
    PubMed     Abstract available

  10. HAUSSMANN R, Noppes F, Brandt MD, Bauer M, et al
    Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?
    Neurosci Lett. 2021 Jun 10:136044. doi: 10.1016/j.neulet.2021.136044.
    PubMed     Abstract available

  11. ANDROVICOVA R, Pfaus JG, Ovsepian SV
    Estrogen Pendulum in Schizophrenia and Alzheimer's Disease: Review of Therapeutic Benefits and Outstanding Questions.
    Neurosci Lett. 2021 Jun 8:136038. doi: 10.1016/j.neulet.2021.136038.
    PubMed     Abstract available

    May 2021
  12. LAKSHMI S, Raghu SV, Elumalai P, Sivan S, et al
    Alkoxylglycerol enhanced activity of Oxyresveratrol in Alzheimer's disease by rescuing Tau protein.
    Neurosci Lett. 2021 May 20:135981. doi: 10.1016/j.neulet.2021.135981.
    PubMed     Abstract available

  13. ZARETSKY DV, Zaretskaia MV
    Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer's disease.
    Neurosci Lett. 2021;756:135959.
    PubMed     Abstract available

  14. ZHANG H, Ge H, Li K
    Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-beta induced neurotoxicity.
    Neurosci Lett. 2021 May 9:135953. doi: 10.1016/j.neulet.2021.135953.
    PubMed     Abstract available

  15. SHAMSIPOUR S, Sharifi G, Taghian F
    Impact of interval training with probiotic (L. plantarum / Bifidobacterium bifidum) on passive avoidance test, ChAT and BDNF in the hippocampus of rats with Alzheimer's disease.
    Neurosci Lett. 2021;756:135949.
    PubMed     Abstract available

    April 2021
  16. ARIOZ BI, Tufekci KU, Olcum M, Durur DY, et al
    Proteome profiling of neuron-derived exosomes in Alzheimer's disease reveals hemoglobin as a potential biomarker.
    Neurosci Lett. 2021;755:135914.
    PubMed     Abstract available

  17. OVSEPIAN SV, O'Leary VB, Hoschl C, Zaborszky L, et al
    Integrated Phylogeny of the Human Brain and Pathobiology of Alzheimer's Disease: A Unifying Hypothesis.
    Neurosci Lett. 2021 Apr 13:135895. doi: 10.1016/j.neulet.2021.135895.
    PubMed     Abstract available

  18. GKANATSIOU E, Sahlin C, Portelius E, Johannesson M, et al
    Characterization of monomeric and soluble aggregated Abeta in Down's syndrome and Alzheimer's disease brains.
    Neurosci Lett. 2021 Apr 10:135894. doi: 10.1016/j.neulet.2021.135894.
    PubMed     Abstract available

  19. RASHTIANI S, Goudarzi I, Jafari A, Rohampour K, et al
    Adenosine monophosphate activated protein kinase (AMPK) is essential for the memory improving effect of adiponectin.
    Neurosci Lett. 2021;749:135721.
    PubMed     Abstract available

    February 2021
  20. SANTOS-GIL DF, Arboleda G, Sandoval-Hernandez AG
    Retinoid X Receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2021 Feb 20:135764. doi: 10.1016/j.neulet.2021.135764.
    PubMed     Abstract available

  21. GIL L, Nino SA, Capdeville G, Jimenez-Capdeville ME, et al
    Neurosci Lett. 2021 Feb 18:135741. doi: 10.1016/j.neulet.2021.135741.
    PubMed     Abstract available

    Evaluation of fluid channels in the human dura and superior sagittal sinus in older patients.
    Neurosci Lett. 2021;746:135649.
    PubMed     Abstract available

  23. LIM KH, Kim SH, Yang S, Chun S, et al
    Advances in multiplex PCR for Alzheimer's disease diagnostics targeting CDK genes.
    Neurosci Lett. 2021 Feb 15:135715. doi: 10.1016/j.neulet.2021.135715.
    PubMed     Abstract available

  24. XU L, Dong Q, Xu L, Zou W, et al
    The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: a case-control study.
    Neurosci Lett. 2021 Feb 9:135710. doi: 10.1016/j.neulet.2021.135710.
    PubMed     Abstract available

    January 2021
  25. LIANG C, Mu Y, Tian H, Wang D, et al
    MicroRNA-140 silencing represses the incidence of Alzheimer's disease.
    Neurosci Lett. 2021 Jan 30:135674. doi: 10.1016/j.neulet.2021.135674.
    PubMed     Abstract available

  26. ZHANG B, Wu L, Zhu Q, Dong Y, et al
    Donepezil attenuates the development of morphine tolerance in rats with cancer-induced bone pain: the role of cortical N-methyl-D-aspartate receptors.
    Neurosci Lett. 2021 Jan 28:135678. doi: 10.1016/j.neulet.2021.135678.
    PubMed     Abstract available

  27. WANG Y, Sheng H, Zhao J, Guo L, et al
    Changes in the prefrontal cortex after the hippocampus was injected with Abeta25-35 via the P35/P25-CDK5-Tau hyperphosphorylation signaling pathway.
    Neurosci Lett. 2021;741:135453.
    PubMed     Abstract available

  28. DIXIT MP, Rahmatkar SN, Raut P, Umekar MJ, et al
    Evidences for agmatine alterations in Abeta1-42induced memory impairment in mice.
    Neurosci Lett. 2021;740:135447.
    PubMed     Abstract available

    December 2020
  29. WANG J, Guo MN, Liu ZZ, Ma SF, et al
    PGC-1alpha reduces Amyloid-beta deposition in Alzheimer's disease: Effect of increased VDR expression.
    Neurosci Lett. 2020;744:135598.
    PubMed     Abstract available

  30. TIAN Z, Dong Q, Wu T, Guo J, et al
    MicroRNA-20b-5p aggravates neuronal apoptosis induced by beta-Amyloid via down-regulation of Ras homolog family member C in Alzheimer's disease.
    Neurosci Lett. 2020 Dec 2:135542. doi: 10.1016/j.neulet.2020.135542.
    PubMed     Abstract available

    November 2020
  31. SONG X, Chen J, Hou Z, Xie N, et al
    Antimicrobial therapy and the potential mechanisms in Alzheimer's disease.
    Neurosci Lett. 2020 Nov 6:135464. doi: 10.1016/j.neulet.2020.135464.
    PubMed     Abstract available

    September 2020
  32. ZHAO A, Li Y, Deng Y
    TNF receptors are associated with tau pathology and conversion to Alzheimer's dementia in subjects with mild cognitive impairment.
    Neurosci Lett. 2020 Sep 15:135392. doi: 10.1016/j.neulet.2020.135392.
    PubMed     Abstract available

    June 2020
  33. TANG Y, Han Y, Yu H, Zhang B, et al
    Increased GABAergic Development in iPSC-Derived Neurons from Patients with Sporadic Alzheimer's Disease.
    Neurosci Lett. 2020 Jun 29:135208. doi: 10.1016/j.neulet.2020.135208.
    PubMed     Abstract available

    May 2020
  34. LIM B, Li QX, Rowe C, Dhiman K, et al
    Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Abeta load and cerebrospinal fluid Abeta in a pilot study of Alzheimer's disease.
    Neurosci Lett. 2020 May 22:135078. doi: 10.1016/j.neulet.2020.135078.
    PubMed     Abstract available

  35. LIU HJ, Li XY, Chen H, Yu HL, et al
    Identification of susceptibility loci for cognitive impairment in a cohort of Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2020 May 10:135034. doi: 10.1016/j.neulet.2020.135034.
    PubMed     Abstract available

  36. DOULAH A, Mahmoodi G, Borujeni MP
    Evaluation of the Pre-Treatment Effect of Centella Asiatica Medicinal Plants on Long-Term potentiation (LTP) in Rat Model of Alzheimer's Disease.
    Neurosci Lett. 2020 May 5:135026. doi: 10.1016/j.neulet.2020.135026.
    PubMed     Abstract available

  37. KONG Y, Peng Q, Lv N, Yuan J, et al
    Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer's disease via activation of adenosine A1 receptor.
    Neurosci Lett. 2020 May 1:135016. doi: 10.1016/j.neulet.2020.135016.
    PubMed     Abstract available

    April 2020
  38. ACERO G, Garay C, Venegas D, Ortega E, et al
    Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid beta 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice.
    Neurosci Lett. 2020;724:134876.
    PubMed     Abstract available

  39. LIU Y, Xu Y, Li M, Pan D, et al
    Multi-target PET evaluation in APP/PS1/tau mouse model of Alzheimer's disease.
    Neurosci Lett. 2020 Apr 8:134938. doi: 10.1016/j.neulet.2020.134938.
    PubMed     Abstract available

    February 2020
  40. ZHANG Z, Gao W, Wang X, Zhang D, et al
    Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APPPS1 mice.
    Neurosci Lett. 2020;720:134749.
    PubMed     Abstract available

    January 2020
  41. LI M, Meng Y, Chu B, Shen Y, et al
    Orexin-A exacerbates Alzheimer's disease by inducing mitochondrial impairment.
    Neurosci Lett. 2020;718:134741.
    PubMed     Abstract available

    December 2019
  42. SUN X, Nie B, Zhao S, Ai L, et al
    Distinct relationships of amyloid-beta and tau deposition to cerebral glucose metabolic networks in Alzheimer's disease.
    Neurosci Lett. 2019;717:134699.
    PubMed     Abstract available

  43. LIU Y, Fang S, Liu LM, Zhu Y, et al
    Hearing loss is an early biomarker in APP/PS1 Alzheimer's disease mice.
    Neurosci Lett. 2019;717:134705.
    PubMed     Abstract available

  44. SINGH A, Agarwal S, Singh S
    Age related neurodegenerative Alzheimer's disease: Usage of traditional herbs in therapeutics.
    Neurosci Lett. 2019 Dec 6:134679. doi: 10.1016/j.neulet.2019.134679.
    PubMed     Abstract available

    November 2019
  45. WANG L, Gao T, Cai T, Li K, et al
    Cerebrospinal fluid levels of YKL-40 in prodromal Alzheimer's disease.
    Neurosci Lett. 2019 Nov 30:134658. doi: 10.1016/j.neulet.2019.134658.
    PubMed     Abstract available

  46. LU X, Moeini M, Li B, Thorin E, et al
    Hypertension accelerates cerebral tissue PO2 disruption in Alzheimer's disease.
    Neurosci Lett. 2019 Nov 11:134626. doi: 10.1016/j.neulet.2019.134626.
    PubMed     Abstract available

    August 2019
  47. FAN W, Sun Y, Shi Z, Wang H, et al
    Mouse Induced Pluripotent Stem Cells-Derived Alzheimer's Disease Cerebral Organoid Culture and Neural Differentiation Disorders.
    Neurosci Lett. 2019 Aug 14:134433. doi: 10.1016/j.neulet.2019.134433.
    PubMed     Abstract available

  48. NONAKA S, Nakanishi H
    Microglial clearance of focal apoptotic synapses.
    Neurosci Lett. 2019;707:134317.
    PubMed     Abstract available

  49. BALU D, Karstens AJ, Loukenas E, Maldonado Weng J, et al
    The role of APOE in transgenic mouse models of AD.
    Neurosci Lett. 2019;707:134285.
    PubMed     Abstract available

  50. CAI D
    Alzheimer's Disease: Advances in Molecular Pathogenesis.
    Neurosci Lett. 2019 Aug 7:134418. doi: 10.1016/j.neulet.2019.134418.

    July 2019
  51. PEREZ-ROCA L, Prada-Dacasa P, Segu-Verges C, Gamez-Valero A, et al
    Glucocerebrosidase regulators SCARB2 and TFEB are up-regulated in Lewy body disease brain.
    Neurosci Lett. 2019;706:164-168.
    PubMed     Abstract available

  52. LIU Y, Wang M, Marcora EM, Zhang B, et al
    Promoter DNA hypermethylation - Implications for Alzheimer's disease.
    Neurosci Lett. 2019;711:134403.
    PubMed     Abstract available

  53. BALES KR, Paul SM
    Targeting apolipoprotein E for treating Alzheimer's disease.
    Neurosci Lett. 2019 Jul 20:134366. doi: 10.1016/j.neulet.2019.134366.
    PubMed     Abstract available

  54. KHATOON R, Rasheed MZ, Rawat M, Mumtaz Alam M, et al
    Effect of melatonin on Abeta42 induced changes in the mitochondrial function related to Alzheimer's disease in Drosophila melanogaster.
    Neurosci Lett. 2019 Jul 17:134376. doi: 10.1016/j.neulet.2019.134376.
    PubMed     Abstract available

  55. DINCER Y, Akkaya C, Mutlu T, Yavuzer S, et al
    DNA repair Gene OGG1 Polymorphism and its relation with oxidative DNA damage in Patients with Alzheimer's Disease.
    Neurosci Lett. 2019 Jul 9:134362. doi: 10.1016/j.neulet.2019.134362.
    PubMed     Abstract available

    June 2019
  56. KOCH G, Martorana A, Caltagirone C
    Transcranial magnetic stimulation: emerging biomarkers and novel therapeutics in Alzheimer's disease.
    Neurosci Lett. 2019 Jun 28:134355. doi: 10.1016/j.neulet.2019.134355.
    PubMed     Abstract available

  57. YAMAGUCHI Y, Ayaki T, Li F, Tsujimura A, et al
    Phosphorylated NF-kappaB subunit p65 aggregates in granulovacuolar degeneration and neurites in neurodegenerative diseases with tauopathy.
    Neurosci Lett. 2019;704:229-235.
    PubMed     Abstract available

  58. CHERNICK D, Ortiz-Valle S, Jeong A, Qu W, et al
    Peripheral Versus Central Nervous System APOE in Alzheimer's Disease:Interplay across the Blood-Brain Barrier.
    Neurosci Lett. 2019 Jun 7:134306. doi: 10.1016/j.neulet.2019.134306.
    PubMed     Abstract available

    May 2019
  59. XIA W
    gamma-Secretase and its modulators: Twenty years and beyond.
    Neurosci Lett. 2019;701:162-169.
    PubMed     Abstract available

    April 2019
  60. WANG L, Jin G, Yu H, Li Q, et al
    Protective effect of Tenuifolin against Alzheimer's disease.
    Neurosci Lett. 2019 Apr 27. pii: S0304-3940(19)30287.
    PubMed     Abstract available

  61. NASERI NN, Wang H, Guo J, Sharma M, et al
    The Complexity of Tau in Alzheimer's Disease.
    Neurosci Lett. 2019 Apr 24. pii: S0304-3940(19)30256.

  62. PARKER J, Mozaffar T, Messmore A, Deignan JL, et al
    Homozygosity for the A431E mutation in PSEN1 presenting with a relatively aggressive phenotype.
    Neurosci Lett. 2019;699:195-198.
    PubMed     Abstract available

  63. LIU JJ, Zhang W, Wang SS, Jia ZQ, et al
    Effects of chain length of saturated fatty acids on Abeta generation in SH-SY5Y cells.
    Neurosci Lett. 2019;698:169-172.
    PubMed     Abstract available

  64. KOBAYASHI T, Nagai M, Da Silva JD, Galaburda AM, et al
    Retrograde transport of masseter muscle-derived neprilysin to hippocampus.
    Neurosci Lett. 2019;698:180-185.
    PubMed     Abstract available

  65. CHAKRABORTY S, Lennon JC, Malkaram SA, Zeng Y, et al
    Serotonergic System, Cognition, and BPSD in Alzheimer's disease.
    Neurosci Lett. 2019 Apr 1. pii: S0304-3940(19)30214.
    PubMed     Abstract available

    March 2019
  66. TORREZ VR, Zimmer ER, Kalinine E, Haas CB, et al
    Memantine mediates astrocytic activity in response to excitotoxicity induced by PP2A inhibition.
    Neurosci Lett. 2019;696:179-183.
    PubMed     Abstract available

  67. DUGGER BN, Hoffman BR, Scroggins A, Serrano GE, et al
    Tau immunoreactivity in peripheral tissues of human aging and select tauopathies.
    Neurosci Lett. 2019;696:132-139.
    PubMed     Abstract available

  68. MENDIVIL-PEREZ M, Velez-Pardo C, Kosik KS, Lopera F, et al
    iPSCs-derived nerve-like cells from familial Alzheimer's disease PSEN 1 E280A reveal increased amyloid-beta levels and loss of the Y chromosome.
    Neurosci Lett. 2019 Mar 20. pii: S0304-3940(19)30194.
    PubMed     Abstract available

  69. CAO J, Zhong MB, Toro CA, Zhang L, et al
    Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis.
    Neurosci Lett. 2019 Mar 16. pii: S0304-3940(19)30171.
    PubMed     Abstract available

  70. NAKAYAMA Y, Sakamoto S, Tsuji K, Ayaki T, et al
    Identification of linear polyubiquitin chain immunoreactivity in tau pathology of Alzheimer's disease.
    Neurosci Lett. 2019 Mar 15. pii: S0304-3940(19)30175.
    PubMed     Abstract available

    February 2019
  71. ELENI G, Erik P, E TC, Kaj B, et al
    A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer s disease.
    Neurosci Lett. 2019 Feb 23. pii: S0304-3940(19)30125.
    PubMed     Abstract available

    January 2019
  72. JULIA T
    Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
    Neurosci Lett. 2019 Jan 24. pii: S0304-3940(19)30055.
    PubMed     Abstract available

  73. STRANG KH, Sorrentino ZA, Riffe CJ, Gorion KM, et al
    Phosphorylation of serine 305 in tau inhibits aggregation.
    Neurosci Lett. 2019;692:187-192.
    PubMed     Abstract available

  74. CHIBA Y, Fujishiro H, Iseki E, Kasanuki K, et al
    Retraction notice to "The cingulate island sign in patients with dementia with Lewy bodies or Alzheimer's disease: A direct comparison between 18F-FDG PET and 123I-IMP SPECT"NSL Volume 683, 14 September 2018, Pages 168-173.
    Neurosci Lett. 2019;690:237.

    December 2018
  75. DONG Q, Teng SW, Wang Y, Qin F, et al
    Sitagliptin protects the cognition function of the Alzheimer's disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings.
    Neurosci Lett. 2018 Dec 28. pii: S0304-3940(18)30898.
    PubMed     Abstract available

    November 2018
  76. WU X, Kosaraju J, Tam KY
    Anti-neuroinflammatory effects of SLOH in Abeta-induced BV-2 microglial cells and 3xTg-AD mice involve the inhibition of GSK-3beta.
    Neurosci Lett. 2018;687:207-215.
    PubMed     Abstract available

  77. YE X, Zhou W, Zhang J
    Association of CSF CD40 levels and synaptic degeneration across the Alzheimer's disease spectrum.
    Neurosci Lett. 2018 Nov 14. pii: S0304-3940(18)30805.
    PubMed     Abstract available

  78. BECKER M, Moore A, Naughton M, Boland B, et al
    Neprilysin degrades murine Amyloid-beta (Abeta) more efficiently than human Abeta: Further implication for species-specific amyloid accumulation.
    Neurosci Lett. 2018;686:74-79.
    PubMed     Abstract available

    October 2018
  79. ALI F, Rahul, Jyoti S, Naz F, et al
    Therapeutic potential of luteolin in transgenic Drosophila model of Alzheimer's disease.
    Neurosci Lett. 2018;692:90-99.
    PubMed     Abstract available

  80. OTA M, Matsuo J, Ishida I, Takano H, et al
    Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease.
    Neurosci Lett. 2018 Oct 24. pii: S0304-3940(18)30730.
    PubMed     Abstract available

  81. ZHANG N, Parr CJC, Birch AM, Goldfinger MH, et al
    The amyloid precursor protein binds to beta-catenin and modulates its cellular distribution.
    Neurosci Lett. 2018;685:190-195.
    PubMed     Abstract available

  82. WANG M, Jing T, Wang X, Yao D, et al
    Beta-secretase/BACE1 promotes APP endocytosis and processing in the endosomes and on cell membrane.
    Neurosci Lett. 2018;685:63-67.
    PubMed     Abstract available

  83. PITCHAI A, Nagarajan N, Vincent SGP, Rajaretinam RK, et al
    Zebrafish bio-assay guided isolation of human acetylcholinesterase inhibitory trans-tephrostachin from Tephrosia purpurea (L.) Pers.
    Neurosci Lett. 2018;687:268-275.
    PubMed     Abstract available

    September 2018
  84. WANG Z, Zhou W, Zhou B, Zhang J, et al
    Association of vascular endothelial growth factor levels in CSF and cerebral glucose metabolism across the Alzheimer's disease spectrum.
    Neurosci Lett. 2018 Sep 29. pii: S0304-3940(18)30660.
    PubMed     Abstract available

    Pharmacogenomics of Alzheimer's and Parkinson's diseases.
    Neurosci Lett. 2018 Sep 17. pii: S0304-3940(18)30624.
    PubMed     Abstract available

    August 2018
  86. LIU D, Cao B, Zhao Y, Huang H, et al
    Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis.
    Neurosci Lett. 2018 Aug 29. pii: S0304-3940(18)30583.
    PubMed     Abstract available

  87. JIN L, Lin L, Li GY, Liu S, et al
    Monosodium glutamate exposure during the neonatal period leads to cognitive deficits in adult Sprague-Dawley rats.
    Neurosci Lett. 2018;682:39-44.
    PubMed     Abstract available

  88. WANG S, Zhang J, Pan T
    APOE epsilon4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer's disease.
    Neurosci Lett. 2018 Aug 22. pii: S0304-3940(18)30575.
    PubMed     Abstract available

  89. CHEN Y, Cao B, Chen X, Ou R, et al
    The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
    Neurosci Lett. 2018 Aug 22. pii: S0304-3940(18)30569.
    PubMed     Abstract available

    July 2018
  90. CHIBA Y, Fujishiro H, Iseki E, Kasanuki K, et al
    The cingulate island sign in patients with dementia with Lewy bodies or Alzheimer's disease: A direct comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Neurosci Lett. 2018;683:168-173.
    PubMed     Abstract available

  91. JIA H, Zhang Y, Huang Y
    Imaging sigma receptors in the brain: New opportunities for diagnosis of Alzheimer's disease and therapeutic development.
    Neurosci Lett. 2018 Jul 21. pii: S0304-3940(18)30512.
    PubMed     Abstract available

  92. BRATOSIEWICZ-WASIK J, Liberski PP, Peplonska B, Styczynska M, et al
    Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
    Neurosci Lett. 2018 Jul 7. pii: S0304-3940(18)30479.
    PubMed     Abstract available

    June 2018
    TSPO ligand PK11195 improves Alzheimer-related outcomes in aged female 3xTg-AD mice.
    Neurosci Lett. 2018 Jun 17. pii: S0304-3940(18)30432.
    PubMed     Abstract available

  94. SHOZAWA H, Oguchi T, Tsuji M, Yano S, et al
    Supratherapeutic concentrations of cilostazol inhibits beta-amyloid oligomerization in vitro.
    Neurosci Lett. 2018;677:19-25.
    PubMed     Abstract available

    May 2018
  95. ZAJKOWICZ A, Gdowicz-Klosok A, Krzesniak M, Janus P, et al
    The Alzheimer's disease-associated TREM2 gene is regulated by p53 tumor suppressor protein.
    Neurosci Lett. 2018 May 26. pii: S0304-3940(18)30388.
    PubMed     Abstract available

  96. ZALLO F, Gardenal E, Verkhratsky A, Rodriguez JJ, et al
    Loss of calretinin and parvalbumin positive interneurones in the hippocampal CA1 of aged Alzheimer's disease mice.
    Neurosci Lett. 2018;681:19-25.
    PubMed     Abstract available

  97. RASHID H, Ahmed T
    Gender Dependent Contribution of Muscarinic Receptors in Memory Retrieval under Sub-Chronic Stress.
    Neurosci Lett. 2018 May 15. pii: S0304-3940(18)30359.
    PubMed     Abstract available

  98. FENG J, Dong L, Zhang J, Han X, et al
    Unique expression pattern of KIBRA in the enteric nervous system of APP/PS1 mice.
    Neurosci Lett. 2018;675:41-47.
    PubMed     Abstract available

  99. CHUNG KM, Hernandez N, Sproul A, Yu WH, et al
    Alzheimer's disease and the autophagic-lysosomal system.
    Neurosci Lett. 2018 May 11. pii: S0304-3940(18)30344.
    PubMed     Abstract available

    April 2018
  100. FANG L, Tang BS, Fan K, Wan CM, et al
    Alzheimer's disease susceptibility genes modify the risk of Parkinson disease and Parkinson's disease-associated cognitive impairment.
    Neurosci Lett. 2018 Apr 23. pii: S0304-3940(18)30305.
    PubMed     Abstract available

  101. KUMAR A, Singh S, Verma A, Mishra VN, et al
    Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer's disease.
    Neurosci Lett. 2018 Apr 9. pii: S0304-3940(18)30276.
    PubMed     Abstract available

  102. WU M, Zhou F, Cao X, Yang J, et al
    Abnormal circadian locomotor rhythms and Per gene expression in six-month-old triple transgenic mice model of Alzheimer's disease.
    Neurosci Lett. 2018;676:13-18.
    PubMed     Abstract available

    March 2018
  103. XU Y, Chen P, Wang X, Yao J, et al
    miR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors.
    Neurosci Lett. 2018;670:94-104.
    PubMed     Abstract available

  104. MAPLE-GRODEM J, Chung J, Lunde KA, Tzoulis C, et al
    Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease.
    Neurosci Lett. 2018;674:123-126.
    PubMed     Abstract available

  105. FANNI D, Gerosa C, Rais M, Ravarino A, et al
    The role of neuropathological markers in the interpretation of neuropsychiatric disorders: Focus on fetal and perinatal programming.
    Neurosci Lett. 2018;669:75-82.
    PubMed     Abstract available

    February 2018
  106. JENSEN HLB, Lillenes MS, Rabano A, Gunther CC, et al
    Expression of nucleotide excision repair in Alzheimer's disease is higher in brain tissue than in blood.
    Neurosci Lett. 2018;672:53-58.
    PubMed     Abstract available

  107. SON Y, Kim JS, Jeong YJ, Jeong YK, et al
    Long-term RF exposure on behavior and cerebral glucose metabolism in 5xFAD mice.
    Neurosci Lett. 2018;666:64-69.
    PubMed     Abstract available

  108. DAI X, Chang P, Li X, Gao Z, et al
    The inhibitory effect of chitosan oligosaccharides on beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) in HEK293 APPswe cells.
    Neurosci Lett. 2018;665:80-85.
    PubMed     Abstract available

  109. LI J, Cheng J
    Apolipoprotein E4 exacerbates ethanol-induced neurotoxicity through augmentation of oxidative stress and apoptosis in N2a-APP cells.
    Neurosci Lett. 2018;665:1-6.
    PubMed     Abstract available

    January 2018
  110. LIN S, Wei L, Ping Y, Xia L, et al
    Upregulated BMP6 pathway involved in the pathogenesis of Abeta toxicity in vivo.
    Neurosci Lett. 2018;664:152-159.
    PubMed     Abstract available

  111. NAGATA K, Mano T, Murayama S, Saido TC, et al
    DNA methylation level of the neprilysin promoter in Alzheimer's disease brains.
    Neurosci Lett. 2018 Jan 12. pii: S0304-3940(18)30003.
    PubMed     Abstract available

    December 2017
  112. ZHANG J, Guo Y, Wang Y, Song L, et al
    Long-term treadmill exercise attenuates Abeta burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer's disease.
    Neurosci Lett. 2017;666:70-77.
    PubMed     Abstract available

  113. DA ROCHA TJ, Silva Alves M, Guisso CC, de Andrade FM, et al
    Association of GPX1 and GPX4 polymorphisms with episodic memory and Alzheimer's disease.
    Neurosci Lett. 2017;666:32-37.
    PubMed     Abstract available

    November 2017
  114. FEHER A, Giricz Z, Juhasz A, Pakaski M, et al
    ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer's disease.
    Neurosci Lett. 2017;664:79-83.
    PubMed     Abstract available

    September 2017
  115. WANG L, Xu XB, You WW, Lin XX, et al
    The cytoplasmic nuclear shuttling of Beclin 1 in neurons with Alzheimer's disease-like injury.
    Neurosci Lett. 2017;661:63-70.
    PubMed     Abstract available

  116. KONG P, Lei P, Zhang S, Li D, et al
    Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2017 Sep 28. pii: S0304-3940(17)30793.
    PubMed     Abstract available

  117. MA X, Liu L, Meng J
    MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer's disease.
    Neurosci Lett. 2017 Sep 22. pii: S0304-3940(17)30785.
    PubMed     Abstract available

  118. BRUNNER D, Flunkert S, Neddens J, Duller S, et al
    SEN1500, a novel oral amyloid-beta aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Neurosci Lett. 2017 Sep 13. pii: S0304-3940(17)30770.
    PubMed     Abstract available

  119. GIAUME C, Saez JC, Song W, Leybaert L, et al
    Connexins and Pannexins in Alzheimer's Disease.
    Neurosci Lett. 2017 Sep 8. pii: S0304-3940(17)30740.
    PubMed     Abstract available

    August 2017
  120. LING J, Huang Y, Zhang L, Wei D, et al
    Association of KIBRA polymorphism with risk of Alzheimer's Disease: Evidence based on 20 case-control studies.
    Neurosci Lett. 2017 Aug 28. pii: S0304-3940(17)30717.
    PubMed     Abstract available

  121. WANG ML, Wei XE, Yu MM, Li PY, et al
    Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort.
    Neurosci Lett. 2017;655:115-120.
    PubMed     Abstract available

  122. ZHANG H, Liu D, Wang Y, Huang H, et al
    Meta-analysis of expression and function of neprilysin in Alzheimer's disease.
    Neurosci Lett. 2017;657:69-76.
    PubMed     Abstract available

    July 2017
  123. RINGMAN JM, Casado M, Van Berlo V, Pa J, et al
    A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30618.
    PubMed     Abstract available

  124. GARCIA-ESCUDERO V, Gargini R, Martin-Maestro P, Garcia E, et al
    Tau mRNA 3'UTR-to-CDS ratio is increased in Alzheimer disease.
    Neurosci Lett. 2017 Jul 6. pii: S0304-3940(17)30558.
    PubMed     Abstract available

    June 2017
  125. PINTANA H, Apaijai N, Kerdphoo S, Pratchayasakul W, et al
    Hyperglycemia induced the Alzheimer's proteins and promoted loss of synaptic proteins in advanced-age female Goto-Kakizaki (GK) rats.
    Neurosci Lett. 2017 Jun 23. pii: S0304-3940(17)30532.
    PubMed     Abstract available

    May 2017
  126. MINAKAWA EN, Miyazaki K, Maruo K, Yagihara H, et al
    Chronic sleep fragmentation exacerbates amyloid beta deposition in Alzheimer's disease model mice.
    Neurosci Lett. 2017 May 26. pii: S0304-3940(17)30452.
    PubMed     Abstract available

  127. ABDALA BB, Dos Antos JM, Goncalves AP, da Motta LB, et al
    Neurosci Lett. 2017 May 26. pii: S0304-3940(17)30451.
    PubMed     Abstract available

  128. WU M, He Y, Zhang J, Yang J, et al
    Co-injection of Abeta1-40 and ApoE4 impaired spatial memory and hippocampal long-term potentiation in rats.
    Neurosci Lett. 2017;648:47-52.
    PubMed     Abstract available

  129. SINGH SK, Srivastav S, Yadav AK, Srikrishna S, et al
    Knockdown of APPL mimics transgenic Abeta induced neurodegenerative phenotypes in Drosophila.
    Neurosci Lett. 2017;648:8-13.
    PubMed     Abstract available

    April 2017
  130. CHEN L, Huang J, Yang L, Zeng XA, et al
    Sleep deprivation accelerates the progression of alzheimer's disease by influencing Abeta-related metabolism.
    Neurosci Lett. 2017;650:146-152.
    PubMed     Abstract available

  131. ZHOU W, Zhang J, Ye F, Xu G, et al
    Plasma neurofilament light chain levels in Alzheimer's disease.
    Neurosci Lett. 2017 Apr 17. pii: S0304-3940(17)30328.
    PubMed     Abstract available

  132. GRAY NE, Zweig JA, Murchison C, Caruso M, et al
    Centella asiatica attenuates Abeta-induced neurodegenerative spine loss and dendritic simplification.
    Neurosci Lett. 2017;646:24-29.
    PubMed     Abstract available

  133. KUNKLE BW, Carney RM, Kohli MA, Naj AC, et al
    Targeted sequencing of ABCA7 identifies splicing, stop-gain and intronic risk variants for Alzheimer disease.
    Neurosci Lett. 2017 Apr 8. pii: S0304-3940(17)30305.
    PubMed     Abstract available

  134. LILLENES MS, Stoen M, Gunther CC, Selnes P, et al
    Mitochondrial transcription factor A (TFAM) rs1937 and AP endonuclease 1 (APE1) rs1130409 alleles are associated with reduced cognitive performance.
    Neurosci Lett. 2017;645:46-52.
    PubMed     Abstract available

    March 2017
  135. JIANG S, Yan C, Qiao Z, Yao H, et al
    Mismatch negativity as a potential neurobiological marker of early-stage Alzheimer disease and vascular dementia.
    Neurosci Lett. 2017;647:26-31.
    PubMed     Abstract available

  136. YAO Z, Yang W, Gao Z, Jia P, et al
    Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease.
    Neurosci Lett. 2017 Mar 18. pii: S0304-3940(17)30246.
    PubMed     Abstract available

  137. NGUYEN KV, Nyhan WL
    Quantification of various APP-mRNA isoforms and epistasis in Lesch-Nyhan disease.
    Neurosci Lett. 2017;643:52-58.
    PubMed     Abstract available

  138. HAN X, Tang S, Dong L, Song L, et al
    Loss of nitrergic and cholinergic neurons in the enteric nervous system of APP/PS1 transgenic mouse model.
    Neurosci Lett. 2017;642:59-65.
    PubMed     Abstract available

  139. DE OLIVEIRA FF, Chen ES, Smith MC, Bertolucci PH, et al
    Longitudinal lipid profile variations and clinical change in Alzheimer's disease dementia.
    Neurosci Lett. 2017 Mar 5. pii: S0304-3940(17)30205.
    PubMed     Abstract available

    February 2017
  140. MIKI Y, Tanji K, Mori F, Kakita A, et al
    PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Neurosci Lett. 2017 Feb 14. pii: S0304-3940(17)30133.
    PubMed     Abstract available

  141. LI L, Zi X, Hou D, Tu Q, et al
    Kruppel-like factor 4 regulates Amyloid-beta (Abeta)-induced neuroinflammation in Alzheimer's disease.
    Neurosci Lett. 2017 Feb 8. pii: S0304-3940(17)30123.
    PubMed     Abstract available

  142. WU Y, Ma Y, Liu Z, Geng Q, et al
    Alterations of myelin morphology and oligodendrocyte development in early stage of Alzheimer's disease mouse model.
    Neurosci Lett. 2017 Feb 5. pii: S0304-3940(17)30113.
    PubMed     Abstract available

  143. CHEN L, Ou S, Zhou L, Tang H, et al
    Formononetin attenuates Abeta25-35-induced cytotoxicity in HT22 cells via PI3K/Akt signaling and non-amyloidogenic cleavage of APP.
    Neurosci Lett. 2017;639:36-42.
    PubMed     Abstract available

    January 2017
  144. MURATA-SHINOZAKI Y, Takahashi T, Matsubara T, Maruyama H, et al
    The origins of rimmed vacuoles and granulovacuolar degeneration bodies are associated with the Wnt signaling pathway.
    Neurosci Lett. 2017;638:55-59.
    PubMed     Abstract available

  145. BRIFFA M, Ghio S, Neuner J, Gauci AJ, et al
    Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Neurosci Lett. 2017;638:12-20.
    PubMed     Abstract available

  146. GABRIEL AJ, Almeida MR, Ribeiro MH, Duraes J, et al
    Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
    Neurosci Lett. 2017 Jan 17. pii: S0304-3940(17)30046.
    PubMed     Abstract available

  147. ZIS P, Strydom A, Buckley D, Adekitan D, et al
    Cognitive ability in Down syndrome and its relationship to urinary neopterin, a marker of activated cellular immunity.
    Neurosci Lett. 2017;636:254-257.
    PubMed     Abstract available

  148. LIU G, Ji H, Liu J, Xu C, et al
    Association of OPRK1 and OPRM1 methylation with mild cognitive impairment in Xinjiang Han and Uygur populations.
    Neurosci Lett. 2017;636:170-176.
    PubMed     Abstract available

  149. CHAI GS, Wang YY, Zhu D, Yasheng A, et al
    Activation of beta2-adrenergic receptor promotes dendrite ramification and spine generation in APP/PS1 mice.
    Neurosci Lett. 2017;636:158-164.
    PubMed     Abstract available

  150. MCINTOSH EC, Jacobson A, Kemmotsu N, Pongpipat E, et al
    Does medial temporal lobe thickness mediate the association between risk factor burden and memory performance in middle-aged or older adults with metabolic syndrome?
    Neurosci Lett. 2017;636:225-232.
    PubMed     Abstract available

    December 2016
  151. ARMIJO E, Gonzalez C, Shahnawaz M, Flores A, et al
    Increased susceptibility to Abeta toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
    Neurosci Lett. 2016;639:74-81.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.